Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Choosing the right ESG stock is about more than just the financial gains it can offer; it is also about its sustainability ...

When it came time to rebuild, the father from Superior, Colorado, wanted to make sure his new home was protected against fire — so he chose a design concept called Passive House. In a ...

However, some architects in the know recommend investing in what’s called a “passive home.” Though still a fairly new trend on the market, these types of homes are designed to be incredibly ...

Batteries die, SD cards get corrupted, settings get messed up, and squirrels trigger thousands of useless images. So why would you make your trail camera strategy more complicated by throwing in ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

Public transport in the Netherlands is some of the best in the world. With huge costs to own cars, it’s no surprise both cycling and public transport thrive so well here. But we imagine it can be ...

The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.

It looks like T-Mobile is now accepting customers into the free beta program for SpaceX’s cellular Starlink service—but only if you have the latest Samsung handsets. On Tuesday, a number of T ...

A multi platform, self updating, lightweight docker stack that use compose to run many passive income applications like Honeygain, EarnApp, IPRoyal Pawns, PacketStream, Peer2Profit, Repocket, Earnfm, ...

8, 2024. (AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...